Rayaldee

Adult Dosing .

Dosage forms:  ER CAP: 30 mcg

hyperparathyroidism, secondary

[30-60 mcg PO qhs]

Start: 30 mcg PO qhs; Info: for CKD stage 4 or 5 patients w/ severe or progressive hyperparathyroidism; routine use not recommended in patients w/ CKD stage 3, refer to KDIGO guidelines; adjust dose by 30 mcg/day 3mo after start or dose change to target serum iPTH in desired range, vitamin D 30-100 ng/mL, Ca in normal range, PO4 <5.5 mg/dL; D/C if iPTH consistently low, vitamin D consistently >100 ng/mL, or Ca consistently high; may restart at lower dose when resolved

renal dosing

[see below]

CKD stage 3-5: no adjustment; Info: not defined if CKD stage 2

HD/PD: not defined

hepatic dosing

[not defined]

Peds Dosing .

Peds dosing is currently unavailable or not applicable for this drug.